Dopamine Receptor Availability in ADHD
Striatal dopamine (D2) receptor availability was determined by iodobenzamide brain SPECT, before and 3 months after methylphenidate (MPH) therapy, in 9 children (mean age, 9.8 years) with attention deficit hyperactivity disorder (ADHD) examined at Gazi University, Ankara, Turkey.
Saved in:
Main Author: | J Gordon Millichap (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2002-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dopamine Transporter Density in ADHD
by: J Gordon Millichap
Published: (2000) -
Dopamine Agonist in Treatment of ADHD with Restless Legs Syndrome and ODD
by: J Gordon Millichap
Published: (2005) -
Reversible Dopamine Transporter Modifications in Response to Methylphenidate Treatment of ADHD
by: J Gordon Millichap
Published: (2005) -
Causative Factors for ADHD: Role of Thyroid Stimulating Hormone Receptor in ADHD
by: J Gordon Millichap, et al.
Published: (2014) -
Treatment of ADHD: Guanfacine Extended Release in ADHD
by: J Gordon Millichap, et al.
Published: (2014)